On 12 February, Novavax, Inc. (NASDAQ:NVAX), announced that enrollment has begun in a Phase 1 clinical trial of its Ebola virus glycoprotein (GP) recombinant nanoparticle vaccine candidate adjuvanted with Matrix-M(TM) (Ebola GP Vaccine) in healthy subjects. On Tuesday shares of Novavax, Inc. (NASDAQ:NVAX) closed at $8.82. Company’s sales growth for last 5 years was 80.20%.

Cytosorbents Corporation (NASDAQ:CTSO) in last trading activity moved up 8.90% to close at $8.93. Company weekly performance is 11.49%. Cytosorbents Corporation (NASDAQ:CTSO) is -30.61% away from its 52 week high.

Solazyme, Inc. (NASDAQ:SZYM), announced it will host a conference call and webcast on Thursday, February 26, 2015 at 4:30 p.m. Eastern Time to discuss its fourth quarter and full year 2014 financial results. On last trading day Solazyme, Inc. (NASDAQ:SZYM) remains unchanged to close at $2.64. Its volatility for the week is 6.42% while volatility for the month is 7.43%. SZYM’s sales growth for past 5 years was 113.40% and its EPS growth for past 5 years was -47.40%. Solazyme, Inc. (NASDAQ:SZYM) monthly performance is 18.39%.

BTIG Research set a $100.00 target price on Cheniere Energy (NYSEMKT:LNG) in a research note released on Tuesday morning. The firm currently has a buy rating on the stock. Cheniere Energy, Inc. (NYSEMKT:LNG) has 4.40% insider ownership while its institutional ownership stands at 90.30%. In last trading activity company’s stock closed at $76.09.

Clovis Oncology, Inc. (NASDAQ:CLVS) will announce its fourth quarter/year-end 2014 financial results on Wednesday, February 25, 2015, after the close of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast at 4:30 p.m. ET that day to discuss the company’s results in greater detail. On last trading day Clovis Oncology, Inc. (NASDAQ:CLVS) moved up 6.15% to close at $73.02. Its volatility for the week is 4.77% while volatility for the month is 5.55%. Clovis Oncology, Inc. (NASDAQ:CLVS) monthly performance is 14.83%.